79 results
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Laboratory Workup COVID ... -19 Specific Medications ... Neuro/Sedation #COVID19 ... NonIntensivist #diagnosis #management
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Treatment Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... Pharmacology #Table #Management
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
the Treatment of COVID ... smfarmhosp_smfh #Drugs #Medications ... #Treatment #COVID19 ... Pharmacology #Table #Management
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Analgesia and Sedation Medications ... due to #COVID19 ... #management ... #covid19 #treatment ... #coronavirus #medications
Multi-System Inflammatory Syndrome in Children (MIS-C) vs. Kawasaki Disease
CDC Case Definition for MIS-C;
 • < 21
Multi-System Inflammatory Syndrome ... disease • Positive COVID ... MISC #Kawasaki #Comparison ... peds #pediatrics #COVID19 ... #Inflammatory #Syndrome
Pharmacologic Treatment of Hyperthyroidism

#Hyperthyroidism #Treatment #Management #Pharmacology #Medications #Comparison #Table #Endocrinology #AAFP #Propylthiouracil #Methimazole
Hyperthyroidism #Treatment #Management ... #Pharmacology #Medications ... #Comparison #Table
â–º
NSAIDs and GI versus CV risk

Follow www.instagram.com/rxnotes for more!

#pharmacology #comparison #cardiology #gi #nsaids #pain #medications #management
#pharmacology #comparison ... #nsaids #pain #medications ... #management #riskfactors
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
dm2 #diabetes #medications ... #overview #management ... #comparison
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... Cytokine Activation Syndrome ... correlate with severe COVID ... #Pharmacology #Management ... #Medications
Recent studies have revealed many attractive therapeutic options, even if some of them remain to be
clinical trials #covid19 ... #sarscov2 #management ... #coronavirus #medications